Skip to Main Content

LabCentral, the biotech incubator in Cambridge, Mass., that has nurtured dozens of startups in a shared working space since 2013, plans to roughly double in size in two years with a new 100,000-square-foot facility in the heart of Kendall Square.

But instead of providing laboratory equipment for scientists to do early-stage research, the new outpost will help startups that have cleared that hurdle to develop potential drugs that the firms eventually hope to test in clinical trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!